{
  "trial_id": "NCT01660997",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Age >18 years.",
      "label": "met"
    },
    {
      "criterion": "ECOG performance status <2.",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients who are receiving any other investigational agents not included in this trial, within 21 days of the start of this trial and throughout the duration of this trial.",
      "label": "triggers"
    },
    {
      "criterion": "Prior therapy for SMM with a proteasome inhibitor.",
      "label": "triggers"
    }
  ],
  "notes": "The patient has symptoms consistent with Shiga-like toxin-producing E. coli (STEC) infection, which may be a contraindication to study enrollment.",
  "_meta": {
    "topic_id": "32",
    "trial_id": "NCT01660997",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}